Michael D. Reed, PharmD, FCCP, FCP, FPPA
Professor Emeritus, Department of Pediatrics-School of Medicine
Case Western Reserve University
Michael D. Reed, PharmD, FCCP, FCP, FPPA, is Professor Emeritus of Pediatrics, School of Medicine, Case Western Reserve University, Cleveland, Ohio. Former positions included: 2015-2017 - Director of the Rainbow Clinical Research Center, Rainbow Babies and Children’s Hospital, University Hospitals Cleveland Medical Center (2015-2017); Director of the Rebecca D. Considine Research Institute, Director of the Division of Clinical Pharmacology and Toxicology and Associate Chair, Department of Pediatrics at Children’s Hospital Medical Center of Akron (CHMCA) [2007-2016], and Professor of Pediatrics, Northeastern Ohio Medical University (NEOMED). Prior to 2007 Dr. Reed held clinical and faculty positions at Case Western University School of Medicine and the University of Virginia, in their Departments of pediatrics.
Dr. Reed received his Bachelor of Science in Pharmacy and post-baccalaureate Doctor of Pharmacy degree from the College of Pharmacy, University of Cincinnati. While obtaining his doctorate he concurrently served a clinical pharmacy/clinical pharmacology residency in pediatrics at the Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Dr. Reed’s research interests focued on the developmental pharmacology and toxicology of drugs in humans and how these data translated into the design of optimal dosing regimens for use in neonates, infants, children, and adults. He has extensive research experience in the design, implementation, and analysis of pharmacokinetic, pharmacodynamic and pharmacogenomic interrelationships as they relate to the maturing infant, child and adolescent. Dr. Reed has received numerous awards, served on numerous governmental (e.g., NIH, FDA) and scholarly committees, as an officer for academic organizations and has authored more than 250 published works describing his original research activities, invited reviews and book chapters.
Senior Associate Editor
Sherry Luedtke, PharmD
Associate Professor, Pharmacy Practice
Texas Tech Health Sciences Center
Dr. Luedtke is one of the founding faculty members of the Texas Tech University Health Sciences Center (TTUHSC) School of Pharmacy and is an Associate Professor of Pharmacy Practice. Dr. Luedtke received her Bachelor of Science and Doctor of Pharmacy degrees from the University of Wisconsin. She completed her practice residency at Meriter Hospital in Madison, Wisconsin and pediatric specialty residency at the University of Kentucky Children’s Hospital.
Dr. Luedtke’s area of practice interest is in neonatology. She has practiced as a clinical specialist providing clinical pharmacy services in neonatology at Northwest Texas Children’s Hospital for over 20 years. Dr. Luedtke has developed neonatal pharmacotherapy educational programs for PPAG, ASHP, and the National Neonatal Nurses Conferences. She has been an invited speaker for national and regional meetings and has authored numerous book chapters and manuscripts on pediatric pharmacotherapy. She currently serves as the Associate Editor for the Journal of Pediatric Pharmacology and Therapeutics and has served as subsection editor for several pediatric pharmacotherapy textbooks. Her honors recognizing clinical and teaching excellence include: PPAG Fellow Recognition (2011), TTUHSC President’s Distinguished Clinician Award, TTUHSC School of Pharmacy Most Influential Professor Awards, Texas Society for Health Systems Pharmacists Best Practice Award, PPAG Best Practice Award, and Texans Caring for Texans Award. Her research interests include neonatal pharmacotherapy and education. Dr. Luedtke has been dedicated to the education of future pediatric practitioners serving a Pediatric Specialty Residency Program Director for 20 years. Sher has served on the Board of Directors and President of the Pediatric Pharmacy Advocacy Group.
Scientific Associate Editor
Gilbert Burckart, PharmD
Associate Director for Pediatrics
Office of Clinical Pharmacology
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Silver Spring, MD
Dr. Gilbert Burckart is presently Associate Director for Pediatrics, Office of Clinical Pharmacology, U.S. Food and Drug Administration. Dr. Burckart has served on the faculties of four universities (Buffalo, Tennessee, Pittsburgh, Southern California) as a Professor of Pharmacy, Pediatrics and Surgery for 33 years prior to coming to the FDA. He has previously served as President of the American College of Clinical Pharmacy and as President of the American College of Clinical Pharmacology. He moved to the US FDA in 2008, and his duties include the direction of the Pediatric Clinical Pharmacology program within the Office of Clinical Pharmacology, and participation in the FDA’s Pediatric Review Committee. His present educational and research program focuses on pediatric drug development studies.
Michael L. Christensen, PharmD
Professor, Clinical Pharmacy & Translational Science and Pediatrics
The University of Tennessee Health Science Center
Michael Christensen received his B.S. in Pharmacy from North Dakota State University in 1978 and Pharm.D. from the University of Tennessee in 1982. He completed a residency in pediatric pharmacotherapy at LeBonheur Children’s Medical Center and a fellowship in pharmacokinetics and pharmacodynamics at St. Jude Children’s Research Hospital. Dr. Christensen spent 6 years at St. Jude Children’s Research Hospital as a clinical pharmacist and developed the metabolic support service. In 1990 Dr. Christensen joined the full-time faculty at the University of Tennessee, College of Pharmacy. Dr. Christensen is a board-certified nutrition support pharmacist since 1993 and currently the Director of the Parenteral Nutrition Service at Le Bonheur Children’s Hospital and recently completed his term as Chair for Board of Pharmaceutical Specialties Specialty Council on Nutrition Support Pharmacy. Dr. Christensen has more than 130 published articles, book chapters and abstracts. His research interests include the design, implementation and analysis of clinical drug trials in children with an emphasis on early phase or pharmacokinetic disposition studies in children; metabolic and nutrient requirements in infants, and evaluation of prescribing trends for therapeutic areas where a high percentage of pediatric drug development programs failed to result in FDA-approved labeling for use in children.
Stephanie J. Phelps, BScPharm, PharmD, FAPhA, FCCP, FNAP, FPPA
Professor Emeritus, Clinical Pharmacy and Translational Science and Pediatrics
The University of Tennessee Health Science Center
email@example.com | 901.229.2219
Stephanie J. Phelps, PharmD received a baccalaureate and doctoral pharmacy degree from Samford University and The University of Tennessee Health Science Center (UTHSC), respectively. She subsequently completed post-doctoral training in pediatrics at LeBonheur Children’s Hospital and UTHSC. Dr. Phelps is currently Professor Emeritus of Clinical Pharmacy and Translational Science and Pediatrics at UTHSC College of Pharmacy. Dr. Phelps has held elected offices in the American Pharmacists Association, American Association of College of Pharmacy and American Society of Health-System Pharmacists and has served on the Board of Directors of the American Society of Parenteral and Enteral Nutrition, National Academies of Practice, and the Pediatric Pharmacist Association. She received the 2009 Tennessee Society of Hospital Pharmacists Distinguished Service Award, PPA’s 2011 Helms Award for Excellence in Pediatric Pharmacy Practice, the 2013 American College of Clinical Pharmacy Outstanding Educator Award, the 2016 University of Tennessee Distinguished Teaching Award and the 2020 University of Kentucky Piecoro Pioneer Award in Pediatric Pharmacy. During her career, she has participated in the education of 5 post-doctoral fellows and over 70 pediatric pharmacy residents and has published more than 100 manuscripts, book chapters, and reviews that focus on pediatric pharmacotherapy. She is editor of The Teddy Bear Book: Pediatric Injectable Drugs.